Lovastatin Tablet
Product Images NDC 66267-506

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 66267-506). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

66267 506 90

This is a description of a medication called Lovastatin 10mg made by NuCare Pharmaceuticals Inc. The medication is in tablet form, containing 90 tablets in a bottle. Each tablet contains Lovastatin 10mg and is round, white or off-white with an engraving of "CTi 141" on one side. The National Drug Code (NDC) for the medication is 66267-0506-90 with a lot number of 000000. The medication is for prescription use only, and the manufacturer's NDC is 61442-141-10 with a serial number of 00000000002. The medication should be stored at a controlled temperature of 68-77°F and kept out of reach of children. The text also includes a warning to consult a doctor before use and to contact the FDA if any negative side effects occur.*

FDA Label Image

Structural Formula (Lov00 0004 01)

FDA Label Image

Table I (Lov00 0004 02)

FDA Label Image

Figure 1 (Lov00 0004 03)

This figure is representing the proportion of participants who did not have an acute major coronary event, which is the primary endpoint, during the follow-up period of up to four years. If there were any additional details or labels, they were not captured by the .*

FDA Label Image

Table Vii (Lov00 0005 04)

This is a table listing drug interactions associated with an increased risk of muscle damage (myopathy/rhabdomyolysis) when prescribed along with certain medications or substances. The table provides prescribing recommendations for healthcare professionals to avoid or limit the use of specific drugs or products when prescribing lovastatin, a medication commonly used to lower cholesterol. The table includes a list of strong CYP3A4 inhibitors, HIV protease inhibitors, boceprevir, telaprevir, nefazodone, cobicistat-containing products, gemfibrozil, cyclosporine, danazol, diltiazem, dronedarone, and grapefruit juice. The prescribing recommendations include avoiding or not exceeding specific dosage limits when used in combination with lovastatin.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.